Gsk Consumer Healthcare

HONG KONG, January 28 - A new study that used state of the art Magnetic Resonance Imaging (MRI) technology reveals that taking alli(R) (orlistat 60 mg) while following a reduced calorie, lower-fat diet can lead to a significant reduction not only in weight but also in dangerous visceral fat.(1) Visceral fat surrounds the vital organs in the abdomen and, in excess, increases the risk of life threatening diseases.(2) The research, carried out over three months at Europe's largest imaging centre, illustrates the changes taking place inside someone's body as they take alli plus diet.